Insulin glargine and lixisenatide and Vaqta Pediatric
Determining the interaction of Insulin glargine and lixisenatide and Vaqta Pediatric and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin Glargine and Lixisenatide
Generic Name: hepatitis a pediatric vaccine
Brand name: Havrix Pediatric, Vaqta Pediatric
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide-Vardenafil
- Insulin glargine and lixisenatide-Vardenafil Hydrochloride
- Insulin glargine and lixisenatide-Vardenafil ODT
- Insulin glargine and lixisenatide-Vardenafil Orally Disintegrating Tablets
- Insulin glargine and lixisenatide-Vardenafil Tablets
- Insulin glargine and lixisenatide-Varenicline
- Vaqta Pediatric-Insulin glargine and lixisenatide Subcutaneous
- Vaqta Pediatric-Insulin glargine, recombinant Subcutaneous
- Vaqta Pediatric-Insulin glulisine
- Vaqta Pediatric-Insulin Glulisine (Cartridges and Pens)
- Vaqta Pediatric-Insulin Glulisine (Vials)
- Vaqta Pediatric-Insulin glulisine Subcutaneous